Find (foundation For Innovative New Diagnostics)
GENEVA, September 1, 2010 - A study(1) published in The New England Journal of Medicine today reports
that a new molecular tuberculosis (TB) test, Xpert(R) MTB/RIF, provides
highly sensitive detection of tuberculosis and drug resistance in low
resource settings more easily and in significantly less time than any
current, widely used diagnostic.